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Abstract
We have investigated the function and mechanisms of 
the CARM1-SNF5 complex in T3-dependent transcrip-
tional activation. Using specific small interfering RNAs 
(siRNA) to knock down coactivators in HeLa α2 cells, 
we found that coactivator associated arginine methyl-
transferase 1 (CARM1) and SWI/SNF complex compo-
nent 5 (SNF5) are important for T3-dependent tran-
scriptional activation. The CARM1- SWI/SNF chroma-
tin remodeling complex serves as a mechanism for the 
rapid reversal of H3-K9 methylation. Importantly, 
siRNA treatment against CARM1 and/or SNF5 in-
creased the recruitment of HMTase G9a to the type 1 
deiodinase (D1) promoter even with T3. Knocking- 
down either CARM1 or SNF5 also inhibited the down- 
regulation of histone macroH2A, which is correlated 
with transcriptional activation. Finally, knocking down 
CARM1 and SNF5 by siRNA impaired the association 
of these coactivators to the D1 promoter, suggesting 
functional importance of CARM1- SNF5 complex in 
T3-dependent transcriptional activation.
Keywords: coactivator-associated arginine methyl-
transferase 1; RNA, small interfering; SMARCB1 pro-
tein, human; transcription factors 
Introduction
Thyroid hormone receptors (TRs) can bind to 
target promoter as monomers, homodimers, or 
heterodimers with retinoid X receptor (RXR) (An et 
al., 1997). TRs can positively or negatively regulate 
transcription dependent on the presence or ab-
sence of hormones and the presence of a positive 
or negative thyroid hormone response element 
(TRE vs nTRE) in its target genes (O'Shea and 
Williams, 2002). In the absence of ligand, TR/RXR 
heterodimers bind to TREs and actively repress 
transcription. The repression by unliganded 
TR/RXR is largely mediated through the recruit-
ment of corepressor proteins such as silencing 
mediator for retinoic acid receptor and thyroid- 
hormone receptor (SMRT) and nuclear hormone 
receptor co-repressor (N-CoR) (Guenther et al., 
2000; Yoon et al., 2003a). Binding of T3 to TR is 
believed to induce conformational changes of the 
receptor, which in turn lead to the release of 
corepressors and the recruitment of coactivators. 
Compared to repression by unliganded TR, trans-
criptional activation by liganded TR is much more 
complex. First, hormone-dependent activation 
appears to involve a significantly larger number of 
cofactors. The current list of nuclear hormone 
receptor (NR) coactivators contains more than 200 
proteins (Narr et al., 2001, McKenna and O'Malley, 
2002). Although it is extremely unlikely that all 
these putative coactivators are required for activa-
tion by nuclear receptors, studies from many 
laboratories provide evidence that many coacti-
vators are required and act in concert to mediate 
transcriptional activation by nuclear receptors 
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(Rosenfield and Glass, 2001; Lee et al., 2002). A 
number of coactivators contain the signature motif 
LXXLL sequences (X, any amino acid) that interact 
with the ligand-binding domain of NRs in a ligand- 
dependent manner (Heery et al., 1997; McInerney 
et al., 1998). 
    Based on the studies of CREB-binding protein 
(CBP) and E1A-binding protein, 300-kDa (p300) 
knockout mice (Kawasaki et al., 1998; Yao et al., 
1998), we know that CBP and p300 are critically 
important for activation by RAR. Their intrinsic 
histone acetyltrasferase (HAT) activity is likely 
critical for their ability to enhance activation by 
many NRs (Kraus et al., 1999; Yi et al., 2007), 
although in some cases the HAT activity of 
p300/CBP-associated factor (PCAF) may be 
preferentially used (Korzus et al., 1998). The 
general requirement for CBP/p300 is consistent 
with the notion that histone acetylation is critically 
important for transcriptional activation from repres-
sive chromatin. In this regard, the major function of 
the steroid hormone receptor coactivator (SRC) 
family, which interacts directly with liganded recep-
tors, is believed to serve as bridging molecules to 
recruit CBP/p300 and other coactivators such as 
CARM1 (Xu and Li, 2003)
    In addition to histone acetylation, histone me-
thylation by CARM1 has been shown to facilitate 
hormone-dependent activation by NRs (Chen et 
al., 1999; Wang et al., 2001). CARM1 methylates 
histone H3 at Arg 2, 17 and 26 (Strahl et al., 2001). 
CARM1 cooperates synergistically with the SRC 
family of coactivators and CBP/p300 to enhance 
transcriptional activation by NRs in transient 
transfection assays (Chen et al., 2000). In addition, 
CARM1 associates with the SWI/SNF complex and 
this association seems to enhance the HMT 
activity of CARM1 (Xu et al., 2004). Finally, 
CARM1 null mice die perinatally and estrogen-res-
ponsive gene expression is aberrant in Carm1-/- 
fibroblasts and embryos, thus indicating a critical 
role for CARM1 in mediating transcriptional regula-
tion by estrogen receptors (Yadav et al., 2003). 
However, given that CARM1 can methylate not 
only histones but also other proteins, it is not clear 
whether histone methylation by CARM1 is critically 
important for transcriptional activation by NRs. In 
addition to the enzymes that covalently modify 
histones, the ATP-dependent chromatin remodel-
ing factor, SWI/SNF, also has a critical role in 
transcriptional activation by NRs (Chiba et al., 
1994; Wong et al., 1995). Human SWI/SNF is 
heterogeneous and known to contain either Brm or 
its related protein Brg1, the ATPase subunits of the 
complexes (Wang et al., 1996). In transient trans-
fection and in vitro transcription assays, both hBrm 
and hBrg1 can facilitate transcriptional activation 
by glucocorticoid receptor (GR), estrogen receptor 
(ER), and retinoic acid receptor (RAR) (Dilworth et 
al., 2000; DiRenzo et al., 2000). Accumulated 
evidence indicates that the coactivators CARM1 
and ATP- dependent chromatin remodeling factor 
SWI/ SNF have critical functions in transcriptional 
activation by nuclear receptors. However, the 
underlying mechanism for requirement of various 
chromatin remodeling factors remains obscure. 
    In this study, we have investigated the function 
and mechanisms of the CARM1-SNF5 complex in 
T3-dependent transcriptional activation. We found 
that CARM1 and SNF5 to a large extent are 
important for T3-dependent transcriptional activa-
tion. The CARM1-SWI/SNF chromatin remodeling 
complex serves as a mechanism for the rapid 
reversal of H3-K9 methylation. Finally, knocking 
down CARM1 and SNF5 by siRNA impaired the 
association of coactivator P300 to the D1 promoter, 
suggesting functional importance of CARM1-SNF5 
complex in T3-dependent activation.
Materials and Methods
Cell culture and siRNA
Cell culture and siRNA treatment were carried out 
essentially as previously described (Yoon et al., 
2003b, 2005). For transfection of siRNAs, HeLa α2 
cells were first cultured in DMEM supplemented 
with 10% charcoal-stripped serum for three days 
and then transfected at a cell confluency of 
~40-50% using Lipofectamine 2000 with amounts 
of siRNA as indicated by the manufacturer’s 
instructions. Two days after transfection, cells were 
collected and processed for western analysis, 
RT-PCR, or chromatin immunoprecipitation (ChIP) 
as indicated. For experiments with T3, α2 cells 
were initially seeded at a density of 4 × 105 
cells/100 mm tissue culture dish. After a 24-h 
incubation, the culture media was replaced with 
DMEM with 10% charcoal-stripped FCS (CS-FCS) 
(Gemini Bio-Products) for three days followed by 
replacement with fresh CS-FCS supplemented with 
10 nM T3 for up to six h. For the experiments 
involving both siRNAs and T3, T3 was added two 
days after siRNA transfection and incubated for 
one h or as indicated in the ChIP assays and six h 
for RT-PCR analysis. The siRNAs for SNF5, CBP, 
PCAF, PRMT5, BRG1, ASC2 and Brm were che-
mically synthesized (Dharmacon Research, Lafay-
ette, Co), de-protected and annealed according to 
the manufacturer’s instruction. The siRNA se-
quences used are as follows: SNF5-1, AAUGUU-
CCGAGGUUCUCUGUA; SNF 5-2, AAUGGCAAC-
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GAUGAGAAGUAC; CBP-1, AAACTCGTCCAAG-
CCATCTTCA; CBP-2, AAACGGAGGTCGCGTTT-
ACAT; CBP-3, AACGGAGGTCGCGTTTACATA; 
PCAF-1, AACCTGTGGTTGAAGGCTCTT; PCAF- 
2, AATCGCCGTGAAGAAAGCGCA; PCAF-3, AA-
ACGAACTCTAATCCTCACT; PRMT5-1, AACGTG-
TATGGCTTCGACATG; PRMT 5-2, AAAGGAGGT-
GGACATCTATAC; BRG1-1, AATGCCAAGCAAG-
ATGTCGAT; BRG1-2, AAATACCTCAGGCTTGAT-
GGA; BRG1-3, AAATCGAGAAGGAGGATGACA; 
ASC2-1, AAGTGGTCCAGGAATAATAAG; ASC2- 
2, AATAAGGATGTCACGCTAACG; ASC2-3, AAA-
GTTACAGGCTCTCTTGAG; Brm- 1, AACGGAAT-
CTTAGCCGATGAA; Brm-2, AAAATTGAGAGCG-
ACTAATCA; Brm-3, AAGAATTACCAGAATACTA-
TG. The pre-designed siRNAs for p300, CARM1, 
p68, SRC1, SRC2 and SRC3 were obtained from 
Dharmacon. The efficiency of siRNA knockdown 
was determined by western analysis using the 
corresponding specific antibodies. 
ChIP assays
For ChIP assays, we first isolated chromatin as 
previously described (Yoon et al., 2005). In brief, 
approximately 2 × 109 α2 cells in 150-mm dishes 
were first treated with PBS containing 1% 
formaldehyde for 10 min, washed twice with PBS, 
and then incubated with 100 mM Tris (pH 9.4) and 
10 mM DTT at 30oC for 15 min. The cells were 
then rinsed twice with PBS and resuspended in 
600 µl of Sol A buffer [10 mM Hepes (pH 7.9), 
0.5% NP-40, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM 
DTT] by pipetting. After a short spin (5 min at 3,000 
rpm), the pellets were resuspended in Sol B [20 
mM Hepes (pH 7.9), 25% glycerol, 0.5% NP-40, 
0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA] con-
taining protease inhibitors followed by vigorous 
pipetting in order to extract the nuclear proteins. 
After centrifugation at 13,000 rpm for 30 min, the 
nuclear pellets were resuspended in IP buffer (1% 
Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH 8.0, 
150 mM NaCl and protease inhibitors) and 
sonicated to break the chromatin into fragments 
with an average length of 0.5-1 kb. The ChIP 
assays were then performed with the indicated 
antibodies essentially as previously described, 
though, SDS was omitted in all buffers. The anti-
bodies against acetylated p300, G9a, Suv39H1, 
TR, Dimethyl R17-H3, AcH3, and TrimethylK9-H3 
were purchased from Upstate Biotechnology. The 
antibody against LSD1 and Brm1 were obtained 
from Santa Cruz Biotechnology. The antibodies 
against JHDM2A, SNF5 and macroH2A were 
kindly provided by Dr. Wong J (East China Uni-
vesity). The antibodies against SRC1, SRC2, 
SRC3, p300 and SNF5 were kindly provided by Dr. 
Qin J (Baylor College of Medicine). The primers 
used for ChIP analysis were previously described 
(Yoon et al., 2005).
RNA extraction and RT-PCR
Total RNA was isolated from α2 cells using an 
RNeasy Mini kit (Qiagen, Tokyo, Japan), according 
to the manufacturer’s specifications. Total RNA 
from each sample was reverse-transcribed with 
random primers using a StrataScriptTM reverse 
transcriptase kit (Stratagene, La Jolla, CA) fol-
lowed by quantitative PCR analysis. Primers for 
ADRB2 amplification were 5'-GGATCGCTACTT-
TGCCATTACTTCACCTTTCA-3' and 5'-CCCCGT-
CCGCCCATCCTGCTCCAC-3'. Primers for BCL3 
amplification were 5'-ACGCCGTGGAAAACAACA-
GCCTTAGCAT-3' and 5'-GAGCGGCGTGTCGTT-
GTGGCAGTTCTTGAG-3'. Primers for FAS ampli-
fication were 5'-CATCGGGCACGTGGGCATTTT-
G-3' and 5'-GGTCCCGCTGGCTGTCCCTGTCC- 
3'. Primers for D1 amplification were 5'-AACCCCC-
ATTTCAGCCACGACAAC-3' and 5'-ATTCAGCAC-
CAGTGGCCTATTACCTT-3'. Primers for GAPDH 
amplification were 5'-CGCGGGGCTCTCCAGAAC-
ATCATCC-3' and 5'-CTCCGACGCCTGCTTCACC-
ACCTTCTT-3'. PCR products were separated by 
agarose gel electrophoresis and visualized by 
ethidium bromide staining.
Real-time PCR analysis
The RT-PCR analysis and quantification were 
performed with Taqman One-Step RT-PCR Master 
Mix Reagents or SYBR Green PCR Master mix 
Reagents [depending on the target RNA (see 
below)] on an ABI Prism 7700 Sequence Detection 
System (Applied biosystem, Foster city, CA). The 
singularity and specificity of amplifications were 
checked by Dissociation Analysis Software. All 
samples were normalized to 18S rRNA (Applied 
biosystem). Primer sequences for amplification of 
the D1 RNA used in qRT-PCR were (F 5'-AG-
CCCATCTACTGCTGGCC-3', R 5'-TGTAGTTCCA-
AGGGCCAGATTT-3', and probe 5'-FAM-AGGC-
TCTACATAATCCAGGAGGGCAGGA-TAMRA-3').
    All reactions were performed in triplicate. Rela-
tive expression levels and SDs were calculated 
using the comparative method. 
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Figure 1. Effect of siRNAs against co-
activators on T3-dependent transcription. 
(A) HeLa α2 cells were transfected with 
control (scrambled) siRNA or siRNA 
against coactivators at the concentration 
indicated. Three days after treatment, 
whole cell extracts were prepared and 
the levels of each protein were de-
termined by western blot. Western blot 
results for HDAC3 served as specificity 
controls. 
Results
Both CARM1 and SNF5 are important for 
T3-dependent activation of the D1 gene
Transcription is a complex, multi-step process 
involving a large number of cofactors that affect 
chromatin remodeling, formation of RNA poly-
merase II preinitiation complex (PIC), transcription 
elongation and the RNA processing (Levine and 
Tjian, 2003). To successfully transcribe a gene, 
each essential cofactor must be recruited to the 
promoter in a dynamic fashion to fulfill its specific 
function and allow the next step to proceed. 
    Using Xenopus laevis oocytes, we previously 
showed that transcriptional activation by liganded 
TR is coupled with not only increased acetylation 
on H3 and H4 but also a robust decrease in H3-K9 
methylation. Furthermore, the pronounced effect 
on histone acetylation was repeatedly observed 
upon T3 treatment, presumably as a combined 
result of corepressor complex dissociation and 
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Figure 1. Continued. (B) The effect on D1 transcriptional activation was analyzed by quantitative real-time PCR analyses. After treatment with siRNAs as 
indicated, the cells were treated with T3 for six h. (C) Total RNA was prepared from each sample and the levels of FAS, ADRB2, and BCL3 were analyzed 
by semi-quantitative PCR. The real time data in (B) was normalized against 18 S rRNA. The level of actin mRNA served as a control in (C). The results 
are shown as means± SD calculated from three independent experiments.
subsequent active recruitment of coactivators by 
liganded TR (Li et al., 2002).
    To address which coactivators are required for 
dynamic regulation between acetylation and 
K9-methylation of H3, we first developed specific 
siRNAs against various coactivators. To test the 
effect and specificity of siRNA constructs, HeLa α2 
cells were transfected with three different siRNAs 
per target coactivator. Two days after transfection, 
HeLa α2 cells were collected, and the effect of 
siRNA treatment was analyzed by western blotting. 
Each siRNA treatment clearly silenced the expres-
sion of their corresponding target proteins. The 
siRNAs against CARM1, p300 and Brm worked 
more efficiently than the siRNAs against p68, 
BRG1 and SNF5 (Figure 1A). As a control, we 
measured the levels of HDAC3, a corepressor for 
nuclear receptors, which showed no significant 
change after any siRNA treatment. In fact, we 
tested and found none of the siRNAs used had any 
significant cross effect. For instance, siRNA 
against BRG1 selectively reduced the level of 
BRG1 protein but had no effect on SNF5, and vice 
versae (data not shown). 
    Having established the specific ‘knock-down’ 
effects caused by each siRNA, we next tested the 
effect of these specific siRNAs on TR activation. To 
assess which coactivators are required for T3- 
dependent activation, we examined the effect of 
knocking down each of them on D1 expression, 
the TR target gene in HeLa α2 cells. For this 
purpose, HeLa α2 cells were treated with siRNA 
specifically against coactivators and a control 
siRNA as shown in Figure 1B. Three days after 
siRNA treatment, T3 (50 nM) was added to the 
tissue cultures and incubated for an additional six 
h. Cells were then harvested and the level of D1 
gene expression was determined by quantitative 
real time PCR. In each experiment, the effective-
ness of the siRNA knock-down was confirmed by 
western analysis. Importantly, knock-down of 
CARM1 and SNF5 significantly crippled T3-depen-
dent activation of the D1 gene, indicating that 
CARM1 and SNF5 are critically important for 
transcriptional activation by TR (Figure 1B). To 
assess whether CARM1 and SNF5 are generally 
required for T3-dependent activation, we tested the 
effect of knocking down CARM1 and SNF5 on the 
expression of FAS, ADRB2, and BCL3, another TR 
target genes in HeLa α2 cells. Three days after 
siRNA treatment, the cells were treated with 10 nM 
T3 for six h, and the levels of FAS, ADRB2 and 
BCL3 gene expression were determined by 
RT-PCR. While treatments with siRNAs against 
coactivators did not alter the transcription level of 
the GAPDH gene, a significant effect was ob-
served for most of the TR target genes (Figure 
1C). In this case, the knockdown of CARM1 and 
SNF5 in general led to a repression of liganded 
TR-mediated transcription from all three TR target 
genes, although the extent of decreased expre-
ssion was gene-dependent. Together, we con-
clude, at least for the genes we have tested, that 
CARM1 and SNF5 are generally required for 
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Figure 2. Both CARM1 and SNF5 are required for the rapid reversal of H3-K9 methylation. HeLa α2 cells were transfected with control 
(scrambled) siRNA or siRNA against coactivators at the concentration indicated. The cells were then treated with T3 for 6 h, after which 
the levels of acetylated and methylated lysine 9 of H3 were determined by ChIP assays using the antibodies indicated. 
T3-dependent transcriptional activation in mam-
malian cells. 
Chromatin remodeling by CARM1-SWI/SNF is 
essential for reversal of H3-K9 methylation
The presence of K9 methylated H3 (mH3-K9) in 
genes repressed by unliganded TR raises question 
as to how the liganded receptor overcomes this 
repressive activity during T3-dependent activation. 
As shown in Figure 2, we found by ChIP assay that 
the level of mH3-K9 in the D1 promoter was rapidly 
decreased upon T3 treatment. As knock-down of 
CARM1 and SNF5 significantly crippled T3-depen-
dent activation of the D1 gene, we next determined 
whether chromatin remodeling by CARM1-SWI/ 
SNF is essential for reversal of H3-K9 methylation. 
To do this, HeLa α2 cells were treated with siRNA 
specifically against coactivators and a control 
siRNA as shown in Figure 1A. Three days after 
siRNA treatment, T3 (10 nM) was added to the 
tissue cultures and incubated for an additional six 
h. Cells were then harvested and histone modi-
fication was determined by ChIP assays. ChIP 
results showed that treatment of cells with T3 led 
to a significant increase of acetylated H3 levels. T3 
treatment also resulted in a reduction of mH3-K9 in 
the D1 target. Interestingly, knocking down either 
CARM1 or SNF5 led to a decrease in histone 
acetylation even of T3 (Figure 2). Knocking-down 
P300 induced a robust decrease of acetylation, as 
expected. Taken together, these results support 
the idea that chromatin remodeling by CARM1- 
SWI/SNF serves as a mechanism for the rapid 
reversal of H3-K9 methylation.
    We next examined the relationship between 
knocking-down CARM1 or SNF5 and increase of 
methyl K9-H3 in the presence of T3. Chip patterns 
obtained on chromatin prepared from α2 cells, 
treated six h with T3 after 3 days of hormone- 
deprivation, demonstrate that CARM1, SRC, p300 
and SNF5 coexist with liganded-TR in the D1 
promoter (Figure 3A). Furthermore, histone methyl-
transferase, G9a, but not Suv39H1, was recruited 
to D1 promoter in the absence of T3. In contrast to 
HMTase, the histone demethylase LSD1 and 
JHDM2A were not found on the D1 promoter 
regardless of T3, implying the presence of other 
demethylases. Importantly, siRNA treatment 
against CARM1 and/or SNF5 increased the 
recruitment of HMTase, G9a compared with control 
siRNAs. This data suggested that the increased 
recruitment of G9a by knocking-down of CARM1- 
SNF5 complex reversed severely T3-induced 
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Figure 3. Knocking down of CARM1-SNF5 complex enhances the recruitment of G9a to the D1 promoter even with T3. (A) The binding of cofactors to the 
D1 promoter was directly tested by ChIP assays using HeLa α2 cells treated with or without T3 for 6 h. (B) HeLa α2 cells were transfected with control 
(scrambled) siRNA or siRNA against CARM1 and/or SNF5 at the concentration indicated. The cells were then treated with T3 for 6 h, after which the bind-
ing of each protein to the D1 promoter were determined by ChIP assays using the antibodies indicated. The results are shown as means± SD calcu-
lated from three independent experiments.
decrease of methyl K9-H3 (Figure 3B).
The functional importance of the CARM1-SNF5 
complex in histone code dynamics
The CARM1 methyltransferase catalytic function is 
required for receptor transactivation (Chen et al., 
1999) with methylation at R17 of histone H3 
serving as a marker of active hormone response 
elements. Recently, the association of ATP- 
remodeling factors with CARM1 revealed a new 
arm in the nuclear hormone-signaling cascade (Xu 
et al., 2004). To study the effect of mR17-H3 on the 
modulation of histone code, we knocked down 
CARM1 and SNF5 individually or in combination by 
siRNA and then tested the effect on histone 
modifications including mR17-H3, acetylation of 
H3, mK9-H3 and mH2A2. As shown in Figure 4, 
we found that knocking down CARM1 and SNF5 
affected the up-regulation of methylation of 
arginine-17 and acetylation of H3 as expected. 
Knocking-down the CARM1-SNF5 complex did not 
appear to affect the recruitment of TR. The down 
regulation of mK9-H3 was abolished by treatment 
with siCARM1 or siSNF5. Interestingly, knocking- 
down either CARM1 or SNF5 inhibited the down- 
regulation of histone macroH2A, which is cor-
related with transcriptional activation (Valley et al., 
2006). Finally, these data indicate that the func-
tional importance of the CARM1-SNF5 complex in 
histone code dynamics is correlated with trans-
criptional activation. 
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Figure 4. The CARM1-SNF5 complex plays an important role in the functional interplay between histone modifications. The same experiments were car-
ried out as in Figure 2, except that antibodies specific for acetylated TR, methylated arginine 17 of H3, and methylated H2A2 were used. 
The CARM1-SNF5 complex is required for the 
ordered recruitment of coactivators in TR-mediated 
transcriptional activation
CARM1 is a coactivator that could have a role in 
recruiting SWI/SNF. CARM1 interacts with the SRC 
coactivator family and CBP/p300 (Schurter et al., 
2001). In addition, CARM1 has been shown 
recently to associate with SWI/SNF in a large 
protein complex termed NUMAC (Xu et al., 2004). 
Thus, CARM1 could function as a bridging factor 
between SRC-CBP/p300 and SWI/SNF. To 
determine if CARM1 and SNF5 affects coactivator 
recruitment, we used a ChIP assay to determine 
how knocking down of CARM1 and/or SNF5 
affects the recruitment of the following coac-
tivators: members of the SRC family (SRC-1, 2 and 
3), CBP/p300, and TRAP/Mediator complex. These 
coactivators have been well characterized and are 
known to have critical roles in transcriptional 
activation by NRs. Furthermore, a recent study 
showed that all of these coactivators were 
recruited to the D1 gene promoter by TR (Metivier 
et al., 2003). We and others have shown by ChIP 
assay that SRC-1, CBP/p300, the TRAP/Mediator 
complex and SWI/SNF were recruited to the target 
promoters by liganded TR (Huang et al., 2003; 
Yoon et al., 2005). ChIP assay also showed that 
their recruitment is affected after knocking down 
CARM1, which had little effect on SRC-2 (Figure 
5). Whether this result reflects a saturated 
recruitment of SRC-2 is not known. Together, the 
CARM1-SNF5 complex is a key bridging factor 
required for the ordered recruitment of coactivators 
in TR-mediated activation.
Discussion
Accumulated evidence indicates that coactivators 
CARM1 and the ATP-dependent chromatin remo-
deling factor SWI/SNF have critical functions in 
transcriptional activation by nuclear receptors. 
However, the underlying mechanism for require-
ment of various chromatin remodeling factors 
remains obscure. CARM1 cooperates synergisti-
cally with the SRC family of coactivators and 
CBP/p300 to enhance gene activation by NRs as 
observed in transient transfection assays (Chen et 
al., 2000). In addition, CARM1 associates with the 
SWI/SNF complex and this association seems to 
enhance CARM1’s HMT activity. Finally, CARM1 
null mice die perinatally and estrogen-responsive 
gene expression is aberrant in Carm1-/- fibroblasts 
and embryos, indicating a critical role for CARM1 
in mediating transcriptional regulation by estrogen 
receptors. However, why histone methylation by 
CARM1 is important for transcription remains to be 
elucidated.
    To investigate the functional importance of 
coactivators in T3-dependent activation, we first 
attempted to generate siRNAs against coactivators 
as indicated (Figure 1). Using these siRNAs, we 
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Figure 5. Knocking down of CARM1-SNF5 complex together impaired the chromatin targeting of coactivators by ligand-bound TR. HeLa α2 cells were 
treated with siRNA against CARM1 and/or SNF5 to knock down their expression individually or in combination. The cells were then treated with T3 (1 nM) 
for six h and the recruitment of coactivators to the D1 promoter, was then determined by ChIP assays using the antibodies indicated. The results were an-
alyzed by real-time PCR and were shown as the percentage of input. The results are shown as means± SD calculated from three independent 
experiments.
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then analyzed the effect of knocking-down coacti-
vators on D1 expression. Knocking down CARM1 
and SNF5 significantly impaired T3-dependent 
activation by TR. Next, to substantiate whether this 
result was gene specific or a general mechanism, 
we tested the effect of knocking down CARM1 and 
SNF5 on the expression of the other three TR 
target genes in HeLa α2 cells. As shown in Figure 
1C, we found that both CARM1 and SNF5 are 
generally required for T3-dependent activation. 
siRNAs against hBrg1 and hBrm also reduced 
T3-dependent activation, but to lesser extent than 
did siSNF5, presumably because of the functional 
redundancy between hBrg1 and hBrm. In addition, 
CARM1 associates with the SWI/SNF complex and 
this association seems to enhance CARM1’s HMT 
activity (Xu et al., 2004). Finally, our data indicate 
that the CARM1-SWI/SNF complex is important for 
T3-dependent transcriptional activation in mamma-
lian cells. 
    Histone methylation is known to be stable 
metabolically (Waterborg, 1993; Kang et al., 2007). 
The presence of K9 methylated H3 (mH3-K9) in 
genes repressed by unliganded TR raises question 
as to how a liganded receptor overcomes this 
repressive activity during T3-dependent activation. 
Surprisingly, as shown in our data (Figure 2), we 
found by ChIP assay that the level of mH3-K9 in 
the D1 promoter decreased rapidly upon T3 
treatment. Here we tested the hypothesis that 
chromatin remodeling by SWI/SNF serves as a 
mechanism for the rapid reversal of H3-K9 
methylation. Finally, we identified that CARM1- 
SNF5 is required for the rapid reversal of H3-K9 
methylation by using siRNAs and ChIP assay. It is 
unclear why a knocking-down of CARM1 and/or 
SNF5 increased the level of methyl K9-H3. CARM1 
has been shown recently to associate with 
SWI/SNF in a large protein complex termed 
NUMAC. In addition, nucleosome unfolding at 
transcriptionally active promoter by chromatin re-
modeling complexes have been reported (Boeger 
et al., 2003; Adkins et al., 2004). Based on these 
studies, the nucleosome clearance presumably 
correlates with the change of histone methylation 
and initiation of transcription. As shown in Figure 
3B, we found that siRNA treatments against 
CARM1 and/or SNF5 increased the recruitment of 
HMTase, G9a. The enhanced recruitment of G9a 
reversed greatly T3-induced decrease of methyl 
K9-H3. Taken together, we believe the chromatin 
remodeling by SWI/SNF is likely to be at lease one 
of the mechanisms for rapid removal of the 
repressive mH3-K9 marker during T3-dependent 
activation, although the involvement of other 
mechanisms such as demethylation cannot be 
excluded. 
    Coactivator that could have a role in recruiting 
SWI/SNF is CARM1. CARM1 interacts with the 
SRC family of coactivators and CBP/p300 
(Schurter et al., 2001). In addition, CARM1 has 
been shown recently to associate with SWI/SNF in 
a large protein complex termed NUMAC. Thus, 
CARM1 could function as a bridging factor 
between SRC-CBP/p300 and SWI/SNF. We 
employed siCARM1 and/or siSNF5 to test whether 
knocking down CARM1 affects the recruitment of 
coactivators involved in T3-dependent activation 
as described. Knocking down the CARM1-SNF5 
complex impaired targeting of coactivators to TR 
target genes, but had little effect on SRC-2. 
Together, the CARM1-SNF5 complex is important 
for the recruitment of a coactivator involved in 
T3-depedent activation.
    In summary, we demonstrated that the CARM1 
complex is generally required for transcriptional 
activation by TR. In principle, as transcription is a 
multi-step process, CARM1 could exert its function 
at one or more of the essential steps. First, it could 
be required for the recruitment of other essential 
coactivators. Second, it could be required for the 
assembly of the pol II preinitiation complex. Third, 
it could be required for the transition from trans-
cription initiation to elongation. One limitation in 
dissecting the role of CARM1 as outlined above is 
that it would be difficult to pinpoint the exact 
function of CARM1 even though knocking down 
CARM1 could have multiple effects on trans-
cription. For instance, as knocking down CARM1 
affects coactivator recruitment, it also might affect 
recruitment of basal transcriptional machinery 
and/or transcriptional elongation. In this case, the 
effect on these subsequent steps could be the 
indirect effect of the coactivator(s) being affected. 
Despite this limitation, this study should yield 
significant insight into the mechanism by which the 
CARM1-SNF5 complex affects transcription.
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